Parcourir MS 2017 num. 12 par sujet "Coût de la maladie"
Voici les éléments 1-1 de 1
(Éditions EDK, Groupe EDP Sciences, 2017)Inflated drug prices necessarily raise the issue of rational allocation of health care resources. The system operated by the NICE agency in the UK attempts to do this by calculating the cost per quality-adjusted life year ...